ストックスクリーナーアプリを入手
0.8362
4.53%
0.0362
前日終値:
$0.80
開ける：
$0.84
24時間の取引高:
69,926
Relative Volume:
1.05
時価総額：
$321.00M
収益：
$71.39M
当期純損益:
$-28.60M
株価収益率:
-0.2236
EPS:
-3.74
ネットキャッシュフロー:
$-12.92M
1週間 パフォーマンス:
+11.96%
1か月 パフォーマンス:
+41.75%
6か月 パフォーマンス:
-38.96%
1年 パフォーマンス:
-45.35%
1日の値動き範囲:
$0.80
$0.84
1週間の範囲:
$0.71
$0.84
52週間の値動き範囲:
$0.48
$3.55
Trinity Biotech Plc Adr Stock (TRIB) Company Profile
TRIB を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TRIB
Trinity Biotech Plc Adr
|
0.8362 | 14.34M | 71.39M | -28.60M | -12.92M | -3.74 |
|
ABT
Abbott Laboratories
|
133.35 | 233.14B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
104.86 | 152.81B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
392.20 | 146.16B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
86.11 | 107.25B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
76.88 | 43.78B | 5.54B | 4.18B | 623.10M | 7.00 |
Trinity Biotech Plc Adr Stock (TRIB) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2015-10-23 | ダウングレード | Craig Hallum | Buy → Hold |
| 2015-09-03 | 開始されました | Raymond James | Outperform |
| 2015-07-29 | 繰り返されました | ROTH Capital | Buy |
| 2008-07-22 | 繰り返されました | Roth Capital | Buy |
| 2008-03-17 | 繰り返されました | Roth Capital | Buy |
| 2007-12-10 | 繰り返されました | Roth Capital | Buy |
| 2007-10-26 | 繰り返されました | Roth Capital | Buy |
すべてを表示
Trinity Biotech Plc Adr (TRIB) 最新ニュース
Trinity Biotech Appoints New Interim CFO - Investing.com India
Trinity Biotech stock hits 52-week low at $0.62 amid challenges - Investing.com
Trinity Biotech (NASDAQ:TRIB) Research Coverage Started at StockNews.com - Armenian Reporter
Trinity Biotech stock hits 52-week low at $0.72 amid challenges By Investing.com - Investing.com South Africa
Trinity Biotech stock hits 52-week low at $0.72 amid challenges - Investing.com
Trinity Biotech secures amended credit to fuel growth By Investing.com - Investing.com South Africa
Trinity Biotech secures amended credit to fuel growth - Investing.com India
Trinity Biotech secures $4m for CGM technology growth - Investing.com
Investor Network: Trinity Biotech Plc Sponsored ADR to Host Earnings Call - ACCESS Newswire
TRIBTrinity Biotech Announces Quarter 1 Financial Results - br.ADVFN.com
Trinity Biotech Announces Quarter 2 Results Revenues of US$36.3m and Operating Profit of US$2.3m - br.ADVFN.com
Trinity Biotech Announces Quarter 4 Financial Results EPS of 17.1 Cent per Share -- an Increase of 10.3% - br.ADVFN.com
Trinity Biotech Announces Quarter 3 Results; Revenues Increase to $35.6m; Operating Profit Increases 56% - br.ADVFN.com
Trinity Biotech stock hits 52-week low at $0.74 amid market challenges - Investing.com
Trinity Biotech Announces Quarter 3 Financial Results, Acquisition of Blood Bank Screening Business and FDA Approval of HIV-2... - br.ADVFN.com
Trinity Biotech Plc ADR (TRIB) Stock: A Year of Market Movement, Down and Up - The InvestChronicle
Market Highlights: Xometry Inc (XMTR) Ends on a Low Note at 36.21 - The Dwinnex
Daily Progress: SiTime Corp (SITM) Drop -20.93, Closing at 176.32 - The Dwinnex
Trinity Biotech Plc ADR (TRIB) Shares Down Despite Recent Market Volatility - The News Heater
Trinity Biotech reports leap in CGM system accuracy - Investing.com
Trinity Biotech secures US funding for HIV tests - Investing.com
Trinity Biotech faces US aid policy impact, PPP loan scrutiny - Investing.com India
Trinity Biotech announces breakthrough in CGM technology - Investing.com India
Trinity Biotech stock hits 52-week low at $0.74 amid challenges By Investing.com - Investing.com South Africa
European Equities Traded in the US as American Depositary Receipts Lower in Wednesday Trading - MSN
Hemoglobin A1c (HbA1c) Testing Market Projected to Reach $1.83 Billion by 2024, Growth Fueled by Rising Prevalence of Diabetes - GlobeNewswire Inc.
Trinity Biotech revises credit terms to boost liquidity - Investing.com India
Trinity Biotech Announces Amended Credit Agreement with Perceptive to Enhance Liquidity and Drive Transformation Plan - GlobeNewswire Inc.
Trinity Biotech advances HIV test manufacturing to offshore site - Investing.com
Trinity Biotech files to sell 0.65M American Depositary shares by selling shareholders - MSN
Earnings call: Trinity Biotech Q3 2024 shows steady growth, strategic moves - Investing.com
What to look for when Lowe’s (LOW) reports Q3 2024 earnings results - AlphaStreet
Trinity Biotech regains Nasdaq compliance - Investing.com India
Trinity Biotech expands into oncology with EpiCapture buyout - Investing.com
Trinity Biotech advances next-gen glucose monitor - Investing.com India
Trinity Biotech to launch CGM tech in India, seeks feedback - Investing.com
North America Blood Testing Market Size & Outlook, 2030 - Grand View Research
Middle East & Africa Blood Testing Market Size & Outlook, 2030 - Grand View Research
Asia Pacific Blood Testing Market Size & Outlook, 2030 - Grand View Research
Trinity Biotech Plc Adr (TRIB) 財務データ
収益
当期純利益
現金流量
EPS
1.68%
0.98%
大文字化:
|
ボリューム (24 時間):